A Longitudinal Study of Movement and Participation in Patients With Cerebral Palsy

Overview

The primary goal of this study is to establish and evaluate an image-based biomarker for the impaired motor control and sensory information processing present in Cerebral palsy (CP) patients

Full Title of Study: “A Longitudinal Study of Movement and Participation in Patients With Cerebral Palsy: a Combined Brain Imaging and Kinematic Analysis”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: June 2017

Detailed Description

Cerebral palsy (CP) may lead to various motor deficits, which further influence the activities and participation. It would be ideal to characterize neural network and motor control model in patients with CP that underlies their clinical behavior by identifying altered neural network and motor control associated with behavioral improvement. The aim of this study is to investigate the brain image and motor control in patients with CP evaluated by multimodal imaging studies utilizing multi-modal techniques and kinematic analysis. This study includes a prospective longitudinal study of patients with CP over one-year. This study will be executed in 3 phases within 3 years: 1st phase (1st years): to establish the multimodal brain images and motor control, and clinical outcomes protocol with a prospective one-year follow-up study in healthy subjects; 2nd phase (2nd years): to establish the brain images and motor control, and clinical outcomes with a prospective one-year follow-up study in older patients with CP; and 3rd phase (3rd years): to establish the brain images and motor control, and clinical outcomes with a prospective one-year follow-up study in younger patients with CP. In a prospective longitudinal study, each participant received 3-times measurements: at the beginning, 6 months later, and one year after the first data collection point

Arms, Groups and Cohorts

  • Healthy Children
    • Inclusion criteria for healthy children were as follows: ages of 4-20 y/o ; good cognition and cooperation; and healthy children.
  • CP subjects
    • Inclusion criteria for subjects with brain damage by CP were as follows: a diagnosis of CP and aged 4-20 years old.

Clinical Trial Outcome Measures

Primary Measures

  • Change from baseline of functional magnetic resonance imaging (fMRI) analysis in 6 months and 12 months
    • Time Frame: baseline, 6 months, 12 months
    • fc(functional connectivity)MRI at resting, active-task fMRI. diffusion tensor imaging (DTI)

Secondary Measures

  • Change from baseline of kinematic analysis in 6 months and 12 months
    • Time Frame: baseline, 6 months, 12 months
    • Kinematic analysis for upper limb and gait analysis
  • Change from baseline of movement and participation for Healthy children and CP in 6 months and 12 months
    • Time Frame: 6 months and 12 months
    • Healthy children and CP: Bruininks- Oseretsky Test of Motor Proficiency II (BOT-2), Wolf Motor Function Test (WMFT), Block and Box test (BBT), Time up and go, Berg Balance Scale (BBS), Functional Independence Measure for Children (WeeFIM), Children Assessment of Participation and Enjoyment (CAPE), and School Function Assessment (SFA).
  • Change from baseline of movement and participation for CP in 6 months and 12 months
    • Time Frame: baseline, 6 months, 12 months
    • Measures for CP also include Gross motor function measure (GMFM), Quality of upper extremity test (QUEST), Pediatric Motor Activity Log (PMAL), Caregiver Functional Use Survey (CFUS), etc.
  • Change from baseline of severity for CP patients in 6 months and 12 months
    • Time Frame: baseline, 6 months, 12 months
    • CP patients: Gross Motor Functional Classification System (GMFCS), Manual Ability Classification System (MACS), Modified Ashworth Scale (MAS), strength and endurance, selective control, etc

Participating in This Clinical Trial

Inclusion Criteria

  • (1) Age: 4-20 y/o (2) Good cognition and cooperation (3) Healthy participants Exclusion Criteria:

  • (1) Motor problems (2) Neurological, orthopedic, or progressive disorders (3) Active medical diseases, such as infection

Gender Eligibility: All

Minimum Age: 4 Years

Maximum Age: 20 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Chang Gung Memorial Hospital
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Chia-Ling Chen, PhD, Principal Investigator, Department of Physical Medicine & Rehabilitation, Chang Gung Memorial Hospital

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.